Literature DB >> 17644737

CD45RO enriches for activated, highly mutated human germinal center B cells.

Stephen M Jackson1, Natessa Harp, Darshna Patel, Jeffrey Zhang, Savannah Willson, Yoon J Kim, Christian Clanton, J Donald Capra.   

Abstract

To date, there is no consensus regarding the influence of different CD45 isoforms during peripheral B-cell development. Examining correlations between surface CD45RO expression and various physiologic processes ongoing during the germinal center (GC) reaction, we hypothesized that GC B cells, like T cells, that up-regulate surface RO should progressively acquire phenotypes commonly associated with activated, differentiating lymphocytes. GC B cells (IgD(-)CD38(+)) were subdivided into 3 surface CD45RO fractions: RO(-), RO(+/-), and RO(+). We show here that the average number of mutations per IgV(H) transcript increased in direct correlation with surface RO levels. Conjunctional use of RO and CD69 further delineated low/moderately and highly mutated fractions. Activation-induced cytidine deaminase (AID) mRNA was slightly reduced among RO(+) GC B cells, suggesting that higher mutation averages are unlikely due to elevated somatic mutation activity. Instead, RO(+) GC B cells were negative for Annexin V, comprised mostly (93%) of CD77(-) centrocytes, and were enriched for CD69(+) cells. Collectively, RO(+) GC B cells occupy what seems to be a specialized niche comprised mostly of centrocytes that may be in transition between activation states. These findings are among the first to sort GC B cells into populations enriched for live mutated cells solely using a single extracellular marker.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644737      PMCID: PMC2190611          DOI: 10.1182/blood-2007-05-087767

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  53 in total

1.  A study on CD45 isoform expression during T-cell development and selection events in the human thymus.

Authors:  Kenjiro Fukuhara; Meinoshin Okumura; Hiroyuki Shiono; Masayoshi Inoue; Yoshihisa Kadota; Shinichiro Miyoshi; Hikaru Matsuda
Journal:  Hum Immunol       Date:  2002-05       Impact factor: 2.850

Review 2.  CD45: a critical regulator of signaling thresholds in immune cells.

Authors:  Michelle L Hermiston; Zheng Xu; Arthur Weiss
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

3.  CD45 isoforms in T cell signalling and development.

Authors:  Louise McNeill; Robin L Cassady; Samiramis Sarkardei; Joanne C Cooper; Geoffrey Morgan; Denis R Alexander
Journal:  Immunol Lett       Date:  2004-03-29       Impact factor: 3.685

Review 4.  Helper T cell-regulated B cell immunity.

Authors:  L J McHeyzer-Williams; L P Malherbe; M G McHeyzer-Williams
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

5.  Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation.

Authors:  S R Dillon; M Mancini; A Rosen; M S Schlissel
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

6.  Hyposialated 185 kDa CD45RA+ molecules attain a high concentration in B lymphoma cells and in activated human B cells.

Authors:  Y Yu; R Rabinowitz; A Polliack; H Ben-Bassat; M Schlesinger
Journal:  Eur J Haematol       Date:  2002-01       Impact factor: 2.997

7.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

8.  Human activation-induced cytidine deaminase is induced by IL-4 and negatively regulated by CD45: implication of CD45 as a Janus kinase phosphatase in antibody diversification.

Authors:  Cheng Zhou; Andrew Saxon; Ke Zhang
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

Review 9.  Activation-induced cytidine deaminase links class switch recombination and somatic hypermutation.

Authors:  Ilmi Okazaki; Kiyotsugu Yoshikawa; Kazou Kinoshita; Masamichi Muramatsu; Hitoshi Nagaoka; Tasaku Honjo
Journal:  Ann N Y Acad Sci       Date:  2003-04       Impact factor: 5.691

10.  Either of the CD45RB and CD45RO isoforms are effective in restoring T cell, but not B cell, development and function in CD45-null mice.

Authors:  Sarah Ogilvy; Christine Louis-Dit-Sully; Joanne Cooper; Robin L Cassady; Denis R Alexander; Nick Holmes
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

View more
  6 in total

1.  Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression.

Authors:  Stephen M Jackson; Natessa Harp; Darshna Patel; Jordan Wulf; Erich D Spaeth; Uzoamaka K Dike; Judith A James; J Donald Capra
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

2.  CD25(+) Bcl6(low) T follicular helper cells provide help to maturing B cells in germinal centers of human tonsil.

Authors:  Haishan Li; C David Pauza
Journal:  Eur J Immunol       Date:  2014-10-27       Impact factor: 5.532

3.  The Prognostic and Predictive Significance of Tumor-Infiltrating Memory T Cells Is Reversed in High-Risk HNSCC.

Authors:  Rebekka Hartan; Sören Schnellhardt; Maike Büttner-Herold; Christoph Daniel; Arndt Hartmann; Rainer Fietkau; Luitpold Distel
Journal:  Cells       Date:  2022-06-17       Impact factor: 7.666

4.  Abortive T follicular helper development is associated with a defective humoral response in Leishmania infantum-infected macaques.

Authors:  Vasco Rodrigues; Mireille Laforge; Laure Campillo-Gimenez; Calaiselvy Soundaramourty; Ana Correia-de-Oliveira; Ricardo Jorge Dinis-Oliveira; Ali Ouaissi; Anabela Cordeiro-da-Silva; Ricardo Silvestre; Jérôme Estaquier
Journal:  PLoS Pathog       Date:  2014-04-24       Impact factor: 6.823

5.  Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases.

Authors:  Samuel J S Rubin; Lawrence Bai; Yeneneh Haileselassie; Gotzone Garay; Chohee Yun; Laren Becker; Sarah E Streett; Sidhartha R Sinha; Aida Habtezion
Journal:  Nat Commun       Date:  2019-06-19       Impact factor: 14.919

6.  Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer.

Authors:  Kenji Fujiyoshi; Juha P Väyrynen; Jennifer Borowsky; David J Papke; Kota Arima; Koichiro Haruki; Junko Kishikawa; Naohiko Akimoto; Tomotaka Ugai; Mai Chan Lau; Simeng Gu; Shanshan Shi; Melissa Zhao; Annacarolina Fabiana Lucia Da Silva; Tyler S Twombly; Hongmei Nan; Jeffrey A Meyerhardt; Mingyang Song; Xuehong Zhang; Kana Wu; Andrew T Chan; Charles S Fuchs; Jochen K Lennerz; Marios Giannakis; Jonathan A Nowak; Shuji Ogino
Journal:  EBioMedicine       Date:  2020-07-08       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.